Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in COVID-19 Patients

被引：0
|
作者：
Wang, Lucas [1 ]
Canela, Victor A. [1 ]
Sidhu, Manavjot [1 ]
机构：
[1] Methodist Dallas Med Ctr, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PUB027
引用
收藏
页码：891 / 891
页数：1
相关论文
共 50 条
  • [31] The effect of sodium-glucose cotransporter-2 inhibitors on graft survival and cardiorenal outcomes in patients with diabetes and heart transplantation
    Hwu, C. -M.
    Yen, F. -S.
    Huang, J. -Y.
    Hsu, C. -C.
    Cheng, W. -Y.
    Wei, J. C.
    DIABETOLOGIA, 2024, 67 : S29 - S29
  • [32] Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
    Nelson, Adam J.
    Harrington, Josephine L.
    Kolkailah, Ahmed A.
    Pagidipati, Neha J.
    McGuire, Darren K.
    HEART FAILURE CLINICS, 2022, 18 (04) : 597 - 607
  • [33] Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
    Porcari, Aldostefano
    Cappelli, Francesco
    Nitsche, Christian
    Tomasoni, Daniela
    Sinigiani, Giulio
    Longhi, Simone
    Bordignon, Luca
    Masri, Ahmad
    Serenelli, Matteo
    Urey, Marcus A.
    Musumeci, Beatrice
    Cipriani, Alberto
    Canepa, Marco
    Eslam, Roza Badr
    Kronberger, Christina
    Chimenti, Cristina
    Zampieri, Mattia
    Allegro, Valentina
    Razvi, Yousuf
    Patel, Rishi
    Ioannou, Adam
    Rauf, Muhammad U.
    Petrie, Aviva
    Whelan, Carol
    Emdin, Michele
    Metra, Marco
    Merlo, Marco
    Sinagra, Gianfranco
    Hawkins, Philip
    Solomon, Scott
    Gillmore, Julian
    Fontana, Marianna
    CIRCULATION, 2023, 148 (25) : E303 - E303
  • [34] Sodium-glucose cotransporter-2 inhibitors reduce risk of nephrolithiasis
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 674 - 675
  • [35] Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory
    Hristova, Mariyana
    MEDICAL HYPOTHESES, 2017, 102 : 61 - 64
  • [36] Expanding Clinical Use of Sodium-glucose Cotransporter-2 Inhibitors?
    Dhawan, Richa
    Chaney, Mark A.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (10) : 2135 - 2138
  • [37] Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections
    Sarafidis, Pantelis
    Papagianni, Aikaterini
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (12) : 943 - 944
  • [38] Sodium-glucose cotransporter-2 inhibitors reduce the risk of gout
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (02): : 190 - 191
  • [39] Effect of sodium-glucose cotransporter-2 inhibitors on pulmonary arterial wedge pressure
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Giannakoulas, George
    Rosenkranz, Stephan
    Fragakis, Nikolaos
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 147 - 149
  • [40] EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS ON SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS INDUCED BY COVID-19
    AlSaraj, Fuad
    Krishnareddy, Kalpana
    Capatos, Gerasmos
    Medhat, Paula
    MEDICINE, 2021, 100 (33)
12345